Parkinson's Disease clinical trials in Florida
44 active Parkinson's Disease trials with a site in Florida. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Low Versus High Load Training and Parkinson's Disease
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Globus Pallidus Stimulation to Treat Insomnia
- A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
- Electrophysiology-based DBS Programming for PD
- A Study of Buntanetap in Participants With PD
- Use of CereGate Therapy for Freezing of Gait in PD
- Listener Training for Improved Intelligibility of People With Parkinson's Disease
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Neurologic Stem Cell Treatment Study
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
- Parkinson's Foundation Surveys
- Parkinson's Foundation PD GENEration Genetic Registry
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
- Registry of Deep Brain Stimulation With the VERCISEā¢ System: Vercise DBS Registry
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Longitudinal Cognitive Assessment by BoCA
- Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
- Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
- Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease
- The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
- Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
- Effects of Stimulation Patterns of Deep Brain Stimulation
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
- Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
- Study in Parkinson Disease of Exercise
- Dysarthria Management for Minor Groups
- Rock Steady Boxing: A Community Based In Person Class
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.